gp100 Melanoma Antigen

"gp100 Melanoma Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A melanosome-associated protein that plays a role in the maturation of the MELANOSOME.

Descriptor ID	D058951
MeSH Number(s)	D12.776.543.306 D12.776.624.301.500 D23.050.285.439.500
Concept/Terms	gp100 Melanoma Antigen gp100 Melanoma Antigen Antigen, gp100 Melanoma Melanoma Antigen, gp100 gp100 Melanoma-Associated Antigen Antigen, gp100 Melanoma-Associated Melanoma-Associated Antigen, gp100 gp100 Melanoma Associated Antigen ME20 Antigen Melanocyte Lineage-Specific Antigen gp100 Melanocyte Lineage Specific Antigen gp100 Melanocyte Protein Pmel 17 Silver Locus Protein Homolog Melanoma-Associated Antigen gp100 Melanoma Associated Antigen gp100 Melanoma-Associated ME20 Antigen Antigen, Melanoma-Associated ME20 ME20 Antigen, Melanoma-Associated Melanoma Associated ME20 Antigen MLSA gp100 Pmel17 Melanoma Antigen Melanoma Antigen, Pmel17 gp100 Melanocyte Differentiation Antigen Melanoma Antigen Glycoprotein 100

Below are MeSH descriptors whose meaning is more general than "gp100 Melanoma Antigen".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Membrane Proteins [D12.776.543]
gp100 Melanoma Antigen [D12.776.543.306]
Neoplasm Proteins [D12.776.624]
Melanoma-Specific Antigens [D12.776.624.301]
gp100 Melanoma Antigen [D12.776.624.301.500]
Biological Factors [D23]
Antigens [D23.050]
Antigens, Neoplasm [D23.050.285]
Melanoma-Specific Antigens [D23.050.285.439]
gp100 Melanoma Antigen [D23.050.285.439.500]

Below are MeSH descriptors whose meaning is related to "gp100 Melanoma Antigen".

Below are MeSH descriptors whose meaning is more specific than "gp100 Melanoma Antigen".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "gp100 Melanoma Antigen" by people in this website by year, and whether "gp100 Melanoma Antigen" was a major or minor topic of these publications.

Bar chart showing 7 publications over 5 distinct years, with a maximum of 2 publications in 2007 and 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2007	0	2	2
2008	0	1	1
2009	0	1	1
2018	1	0	1
2019	0	2	2

Below are the most recent publications written about "gp100 Melanoma Antigen" by people in Profiles.

Lowe KL, Cole D, Kenefeck R, OKelly I, Lepore M, Jakobsen BK. Novel TCR-based biologics: mobilising T cells to warm 'cold' tumours. Cancer Treat Rev. 2019 Jul; 77:35-43.

View in: PubMed
Chakraborty P, Chatterjee S, Kesarwani P, Thyagarajan K, Iamsawat S, Dalheim A, Nguyen H, Selvam SP, Nasarre P, Scurti G, Hardiman G, Maulik N, Ball L, Gangaraju V, Rubinstein MP, Klauber-DeMore N, Hill EG, Ogretmen B, Yu XZ, Nishimura MI, Mehrotra S. Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells. J Biol Chem. 2019 06 07; 294(23):9198-9212.

View in: PubMed
Eby JM, Smith AR, Riley TP, Cosgrove C, Ankney CM, Henning SW, Paulos CM, Garrett-Mayer E, Luiten RM, Nishimura MI, Baker BM, Le Poole IC. Molecular properties of gp100-reactive T-cell receptors drive the cytokine profile and antitumor efficacy of transgenic host T cells. Pigment Cell Melanoma Res. 2019 01; 32(1):68-78.

View in: PubMed
Salem ML, Díaz-Montero CM, Al-Khami AA, El-Naggar SA, Naga O, Montero AJ, Khafagy A, Cole DJ. Recovery from cyclophosphamide-induced lymphopenia results in expansion of immature dendritic cells which can mediate enhanced prime-boost vaccination antitumor responses in vivo when stimulated with the TLR3 agonist poly(I:C). J Immunol. 2009 Feb 15; 182(4):2030-40.

View in: PubMed
Abad JD, Wrzensinski C, Overwijk W, De Witte MA, Jorritsma A, Hsu C, Gattinoni L, Cohen CJ, Paulos CM, Palmer DC, Haanen JB, Schumacher TN, Rosenberg SA, Restifo NP, Morgan RA. T-cell receptor gene therapy of established tumors in a murine melanoma model. J Immunother. 2008 Jan; 31(1):1-6.

View in: PubMed
Wrzesinski C, Paulos CM, Gattinoni L, Palmer DC, Kaiser A, Yu Z, Rosenberg SA, Restifo NP. Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells. J Clin Invest. 2007 Feb; 117(2):492-501.

View in: PubMed
Cassaday RD, Sondel PM, King DM, Macklin MD, Gan J, Warner TF, Zuleger CL, Bridges AJ, Schalch HG, Kim KM, Hank JA, Mahvi DM, Albertini MR. A phase I study of immunization using particle-mediated epidermal delivery of genes for gp100 and GM-CSF into uninvolved skin of melanoma patients. Clin Cancer Res. 2007 Jan 15; 13(2 Pt 1):540-9.

View in: PubMed

People

Explore

Similar Concepts

Top Journals